BFM
ORIC icon

Boothbay Fund Management’s Oric Pharmaceuticals ORIC Stock Holding History

Boothbay Fund Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$785K Sell
61,957
-156,653
-72% -$1.78M 0.01% 1078
2025
Q4 		$1.79M Buy
218,610
+107,777
+97% +$1.24M 0.03% 596
2025
Q3 		$1.33M Buy
+110,833
New +$1.17M 0.02% 721
2023
Q2 		– Sell
-20,232
Closed -$115K – 2161
2023
Q1 		$115K Buy
20,232
+9,004
+80% +$47K ﹤0.01% 1887
2022
Q4 		$66.1K Buy
+11,228
New +$37.9K ﹤0.01% 1856

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Boothbay Fund Management's ORIC Position: Q1 2026 in Review

Boothbay Fund Management reduced its Oric Pharmaceuticals (ORIC) stake by 72% in Q1 2026, selling an estimated $1.78M and leaving 61,957 shares worth $785K. The position accounts for 0.01% of the portfolio, ranked #1078.

Boothbay Fund Management first reported a position in ORIC in Q4 2022 and has held it in 5 quarters since. The position peaked at $1.79M in Q4 2025. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Boothbay Fund Management held 61,957 shares of Oric Pharmaceuticals worth $785K as of Q1 2026.
  • Boothbay Fund Management sold 156,653 Oric Pharmaceuticals shares in Q1 2026, an estimated $1.78M.
  • Oric Pharmaceuticals made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1078 holding.
  • Boothbay Fund Management first reported a position in Oric Pharmaceuticals in Q4 2022 and has held it in 5 quarters since.
  • Boothbay Fund Management's Oric Pharmaceuticals position peaked at $1.79M in Q4 2025.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.